CP
Cipher Pharmaceuticals Inc.
CPHRF · OTC
$10.35 -1.46% (-$0.15)
1M +0.98%
Market Cap $262.7M
P/E Ratio 9.06x
Div. Yield -
ROE 22.74%
Bulios Fair Price
$14.37
38.9% upside
Current Price
$10.35
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CPHRF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
85 /100
Cheap P/E 9.06x
EV/EBITDA 10.39x
P/S 5.33x
Growth
80 /100
Growing EPS growth 2.62%
Rev. growth 35.41%
FCF growth 42.27%
Profitability
100 /100
Strong Gross margin 70.55%
Net margin 58.80%
Op. margin 38.76%
Quality
89 /100
Excellent ROIC 23.22%
ROE 22.74%
ROA 18.51%
Debt
97 /100
Low Debt/Equity 0.00x
Current ratio 1.59x
Int. coverage 47.88x
Stability
41 /100
Moderate Beta 0.48x
Rev. volatility 30.89%
EPS volatility 95.09%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CPHRF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Craig J. Mull
Employees
6
Headquarters
Mississauga
Upcoming events
05 NOV
Earnings
Upcoming earnings report